Koru Medical transferred with Buy rating at B. Riley

B. Riley put a Buy rating on Koru Medical Systems with a $4 price target following a transfer of coverage. The analyst is optimistic on the shares, citing the multiple tracks driving growth highlighted in the early progress towards management’s Vision 2026 goals. Easing patient burden and administration time, Koru is poised to take advantage of prefilled syringes, the analyst tells investors in a research note.